The benefits of the AstraZeneca vaccine outweigh the risks – EMA

The European Medicines Agency (EMA) It said Tuesday that its investigation into the possible side effects of AstraZeneca’s coronavirus vaccine is ongoing, Reuters reported.

Featured statements

“The current situation is not unexpected.”

“We have asked the experts to investigate whether there is a link between the vaccine and blood clot events.”

“We are evaluating all incidents on a case-by-case basis.”

“Experts are expected to reach a conclusion on Thursday.”

“We will inform the public immediately after the meeting on Thursday.”

“There is no indication that the vaccine has caused incidents of blood clots.”

“The number of events is not greater than that observed in a normal population.”

“The benefits of the vaccine outweigh the risks.”

Market reaction

These comments do not appear to have a significant impact on market sentiment. At the time of writing, the Euro Stoxx 50 index it was up 0.4% on the day to 3,845.

.

You may also like